カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗コリン性酔い止め薬の世界市場見通し2023年-2029年

◆英語タイトル：Anticholinergic Travel Sickness Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5673）◆商品コード：MMG23JU5673
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anticholinergic Travel Sickness Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの抗コリン性酔い止め薬市場規模と予測を収録しています。・世界の抗コリン性酔い止め薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗コリン性酔い止め薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗コリン性酔い止め薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「大人用」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗コリン性酔い止め薬のグローバル主要企業は、GlaxoSmithKline、 Baxter Internationalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗コリン性酔い止め薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗コリン性酔い止め薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗コリン性酔い止め薬市場：タイプ別市場シェア、2022年
・大人用、小人用

世界の抗コリン性酔い止め薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗コリン性酔い止め薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の抗コリン性酔い止め薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗コリン性酔い止め薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗コリン性酔い止め薬のグローバル売上、2018年-2023年
・主要企業における抗コリン性酔い止め薬のグローバル売上シェア、2022年
・主要企業における抗コリン性酔い止め薬のグローバル販売量、2018年-2023年
・主要企業における抗コリン性酔い止め薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GlaxoSmithKline、 Baxter International

*************************************************************

・調査・分析レポートの概要
抗コリン性酔い止め薬市場の定義
市場セグメント
世界の抗コリン性酔い止め薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗コリン性酔い止め薬市場規模
世界の抗コリン性酔い止め薬市場規模：2022年 VS 2029年
世界の抗コリン性酔い止め薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗コリン性酔い止め薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗コリン性酔い止め薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：大人用、小人用
抗コリン性酔い止め薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
抗コリン性酔い止め薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗コリン性酔い止め薬市場規模 2022年と2029年
地域別抗コリン性酔い止め薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、 Baxter International
...

Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
This report aims to provide a comprehensive presentation of the global market for Anticholinergic Travel Sickness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticholinergic Travel Sickness Drugs. This report contains market size and forecasts of Anticholinergic Travel Sickness Drugs in global, including the following market information:
Global Anticholinergic Travel Sickness Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anticholinergic Travel Sickness Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Anticholinergic Travel Sickness Drugs companies in 2022 (%)
The global Anticholinergic Travel Sickness Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adults Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anticholinergic Travel Sickness Drugs include GlaxoSmithKline and Baxter International etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticholinergic Travel Sickness Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticholinergic Travel Sickness Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Type, 2022 (%)
Adults
Children
Global Anticholinergic Travel Sickness Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Other
Global Anticholinergic Travel Sickness Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticholinergic Travel Sickness Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anticholinergic Travel Sickness Drugs revenues share in global market, 2022 (%)
Key companies Anticholinergic Travel Sickness Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Anticholinergic Travel Sickness Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Baxter International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticholinergic Travel Sickness Drugs, market overview.
Chapter 2: Global Anticholinergic Travel Sickness Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anticholinergic Travel Sickness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticholinergic Travel Sickness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anticholinergic Travel Sickness Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anticholinergic Travel Sickness Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticholinergic Travel Sickness Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticholinergic Travel Sickness Drugs Overall Market Size
2.1 Global Anticholinergic Travel Sickness Drugs Market Size: 2022 VS 2029
2.2 Global Anticholinergic Travel Sickness Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anticholinergic Travel Sickness Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anticholinergic Travel Sickness Drugs Players in Global Market
3.2 Top Global Anticholinergic Travel Sickness Drugs Companies Ranked by Revenue
3.3 Global Anticholinergic Travel Sickness Drugs Revenue by Companies
3.4 Global Anticholinergic Travel Sickness Drugs Sales by Companies
3.5 Global Anticholinergic Travel Sickness Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anticholinergic Travel Sickness Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anticholinergic Travel Sickness Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anticholinergic Travel Sickness Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anticholinergic Travel Sickness Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anticholinergic Travel Sickness Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anticholinergic Travel Sickness Drugs Market Size Markets, 2022 & 2029
4.1.2 Adults
4.1.3 Children
4.2 By Type – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
4.2.1 By Type – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
4.2.2 By Type – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
4.2.3 By Type – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
4.3.1 By Type – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
4.3.2 By Type – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
4.3.3 By Type – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Anticholinergic Travel Sickness Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anticholinergic Travel Sickness Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Other
5.2 By Application – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
5.2.1 By Application – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
5.2.2 By Application – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
5.2.3 By Application – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
5.3.1 By Application – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
5.3.2 By Application – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
5.3.3 By Application – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Anticholinergic Travel Sickness Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anticholinergic Travel Sickness Drugs Market Size, 2022 & 2029
6.2 By Region – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
6.2.1 By Region – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
6.2.2 By Region – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
6.2.3 By Region – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
6.3.1 By Region – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
6.3.2 By Region – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
6.3.3 By Region – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.4.2 By Country – North America Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.4.3 US Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.4.4 Canada Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.4.5 Mexico Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.5.3 Germany Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.4 France Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.5 U.K. Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.6 Italy Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.7 Russia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.9 Benelux Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.6.3 China Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.4 Japan Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.5 South Korea Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.7 India Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.7.2 By Country – South America Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.7.3 Brazil Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.7.4 Argentina Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.8.3 Turkey Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.4 Israel Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.6 UAE Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Baxter International
7.2.1 Baxter International Company Summary
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Anticholinergic Travel Sickness Drugs Major Product Offerings
7.2.4 Baxter International Anticholinergic Travel Sickness Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Baxter International Key News & Latest Developments
8 Global Anticholinergic Travel Sickness Drugs Production Capacity, Analysis
8.1 Global Anticholinergic Travel Sickness Drugs Production Capacity, 2018-2029
8.2 Anticholinergic Travel Sickness Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anticholinergic Travel Sickness Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anticholinergic Travel Sickness Drugs Supply Chain Analysis
10.1 Anticholinergic Travel Sickness Drugs Industry Value Chain
10.2 Anticholinergic Travel Sickness Drugs Upstream Market
10.3 Anticholinergic Travel Sickness Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anticholinergic Travel Sickness Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anticholinergic Travel Sickness Drugs in Global Market
Table 2. Top Anticholinergic Travel Sickness Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anticholinergic Travel Sickness Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anticholinergic Travel Sickness Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anticholinergic Travel Sickness Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Anticholinergic Travel Sickness Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anticholinergic Travel Sickness Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anticholinergic Travel Sickness Drugs Product Type
Table 9. List of Global Tier 1 Anticholinergic Travel Sickness Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticholinergic Travel Sickness Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2024-2029
Table 16. By Application – Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2024-2029
Table 21. By Region – Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anticholinergic Travel Sickness Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Anticholinergic Travel Sickness Drugs Sales (Units), 2024-2029
Table 26. By Country - North America Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anticholinergic Travel Sickness Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Anticholinergic Travel Sickness Drugs Sales, (Units), 2024-2029
Table 30. By Country - Europe Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anticholinergic Travel Sickness Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Anticholinergic Travel Sickness Drugs Sales, (Units), 2024-2029
Table 34. By Region - Asia Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anticholinergic Travel Sickness Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Anticholinergic Travel Sickness Drugs Sales, (Units), 2024-2029
Table 38. By Country - South America Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anticholinergic Travel Sickness Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Anticholinergic Travel Sickness Drugs Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Sales, (Units), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Anticholinergic Travel Sickness Drugs Product Offerings
Table 48. GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Baxter International Company Summary
Table 51. Baxter International Anticholinergic Travel Sickness Drugs Product Offerings
Table 52. Baxter International Anticholinergic Travel Sickness Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Baxter International Key News & Latest Developments
Table 54. Anticholinergic Travel Sickness Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 55. Global Anticholinergic Travel Sickness Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Anticholinergic Travel Sickness Drugs Production by Region, 2018-2023 (Units)
Table 57. Global Anticholinergic Travel Sickness Drugs Production by Region, 2024-2029 (Units)
Table 58. Anticholinergic Travel Sickness Drugs Market Opportunities & Trends in Global Market
Table 59. Anticholinergic Travel Sickness Drugs Market Drivers in Global Market
Table 60. Anticholinergic Travel Sickness Drugs Market Restraints in Global Market
Table 61. Anticholinergic Travel Sickness Drugs Raw Materials
Table 62. Anticholinergic Travel Sickness Drugs Raw Materials Suppliers in Global Market
Table 63. Typical Anticholinergic Travel Sickness Drugs Downstream
Table 64. Anticholinergic Travel Sickness Drugs Downstream Clients in Global Market
Table 65. Anticholinergic Travel Sickness Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anticholinergic Travel Sickness Drugs Segment by Type in 2022
Figure 2. Anticholinergic Travel Sickness Drugs Segment by Application in 2022
Figure 3. Global Anticholinergic Travel Sickness Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anticholinergic Travel Sickness Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anticholinergic Travel Sickness Drugs Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Anticholinergic Travel Sickness Drugs Revenue in 2022
Figure 9. By Type - Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anticholinergic Travel Sickness Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anticholinergic Travel Sickness Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 23. US Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 37. China Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anticholinergic Travel Sickness Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anticholinergic Travel Sickness Drugs Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Anticholinergic Travel Sickness Drugs by Region, 2022 VS 2029
Figure 54. Anticholinergic Travel Sickness Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

抗コリン性酔い止め薬は、特に乗り物酔いを防ぐために使用される薬剤の一群です。これらの薬剤は、主に副交感神経系に影響を与えることによって酔いの症状を軽減する役割を果たします。酔いは、通常は自動車、船、飛行機などの乗り物に乗っているときに経験する不快な症状であり、吐き気やめまい、発汗などを伴うことが多いです。抗コリン性酔い止め薬は、その特性と効果から、多くの人々にとって重要な治療手段となっています。

抗コリン性とは、副交感神経系の伝達物質であるアセチルコリンの働きを抑えることを指します。これにより、乗り物酔いの原因となる内耳の平衡感覚に関連する神経信号の伝達が阻害され、酔いの症状が軽減されます。抗コリン性酔い止め薬は、呼吸器系や消化器系の筋肉の緊張を和らげる効果もあります。これにより、連動して吐き気の軽減にも寄与します。

抗コリン性酔い止め薬にはいくつかの種類がありますが、最も一般的なものはスコポラミンとメクリジンです。スコポラミンは、専用の皮膚パッチとして使用されることが多く、発症前に皮膚に貼り付けることで持続的に薬を体内に供給します。これにより、長時間の旅行においても持続的な効果を発揮します。一方、メクリジンは内服薬として利用され、一般的には旅行の直前に服用することが推奨されます。これらの薬剤は、乗り物酔いに悩む人にとって非常に有用ですが、副作用も存在します。特に、口渇、眠気、視力のぼやけなどが一般的に報告されているため、注意が必要です。

抗コリン性酔い止め薬の主な用途は、乗り物酔いの予防と治療です。多くの人が旅行中に経験する酔いの症状は、特に長距離の移動や、高速道路を走行する際に顕著に現れることがあります。抗コリン性酔い止め薬は、これらの状況で酔いを防ぐために有効です。また、これらの薬は術後の吐き気や嘔吐の予防にも使用されることがあります。特に麻酔を使用する手術後は、患者が吐き気を感じることが多いため、抗コリン性薬剤が推奨されることがあります。

抗コリン性酔い止め薬に関する関連技術としては、薬物投与のデリバリーシステムが挙げられます。スコポラミンパッチの登場は、従来の内服薬よりも安定した血中濃度を保つ手法として注目されています。また、近年では遺伝子組み換え技術を用いた新たな薬剤の開発も進められており、より効果的で副作用の少ない抗コリン薬の創出が期待されています。

近年では、抗コリン性酔い止め薬の使用における副作用に関する研究が進んでおり、慎重な投与が求められています。特に高齢者において、副作用が顕著に現れることから、使用には細心の注意が必要です。また、抗コリン性薬剤は、認知機能に影響を与える可能性があるため、長期間の使用は推奨されません。

さらに、抗コリン性酔い止め薬は一部の薬剤と相互作用を引き起こすことがあるため、他の医療薬を服用している場合には特に注意が必要です。たとえば、抗ヒスタミン薬や抗うつ薬と併用すると、抗コリン性の副作用が増強されることがあります。医師や薬剤師と相談し、併用薬に関する情報をしっかり得ることが重要です。

抗コリン性酔い止め薬は、旅行や移動時の不快な酔いを軽減する手段として有効ですが、その使用に際しては適切な知識と注意が必要です。副作用を理解し、適切な使用方法を守ることで、効果的に酔いを防ぐことが可能になります。特に旅行を楽しむ際には、これらの薬剤を適切に活用し、快適な移動を実現するために役立てることが求められます。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗コリン性酔い止め薬の世界市場見通し2023年-2029年(Anticholinergic Travel Sickness Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ミドスタウリン薬の世界市場見通し2023年-2029年
  • パシレオチド薬の世界市場見通し2023年-2029年
  • ソマチリン薬の世界市場見通し2023年-2029年
  • ランレオチド薬の世界市場見通し2023年-2029年
  • シニフォルドラッグの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆